# Gregory A. Masters

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/gregory-a-masters/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,189 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 51 |
| i10-index | 86 |
| Last Known Institution | Christiana Care Health System |
| OpenAlex ID | https://openalex.org/A5071796883 |
| ORCID iD | https://orcid.org/0000-0002-8538-3826 |
| Works | 338 |

## Researcher papers

- [Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study](https://scholariq.org/papers/standard-dose-versus-high-dose-conformal-radiotherapy-with-concurrent-and/)
- [Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events](https://scholariq.org/papers/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immune/)
- [Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients](https://scholariq.org/papers/lectin-type-oxidized-ldl-receptor-1-distinguishes-population-of-human/)
- [Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer](https://scholariq.org/papers/long-term-results-of-nrg-oncology-rtog-0617-standard-versus-high-dose/)
- [Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study](https://scholariq.org/papers/gefitinib-versus-placebo-in-completely-resected-non-small-cell-lung-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Researcher university

- [Christiana Care Health System](https://scholariq.org/institutions/christiana-care-health-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.